Psychopharmacology for Patients With Intellectual Disability
The Carlat Psychiatry Report, Volume 15, Number 9&10, September 2017
https://www.thecarlatreport.com/newsletter-issue/tcprv15n9-10/
Issue Links: Learning Objectives | Editorial Information
Julie Gentile, MD
Professor of psychiatry at the Boonshoft School of Medicine, Wright State University. Project director for Ohio’s Coordinating Center of Excellence in Mental Illness & Intellectual Disability.
Dr. Gentile has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
David Dixon, DO
Clinical chief resident, Wright State University, Department of Psychiatry.
Dr. Dixon has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Prescribing psychotropic medications in patients with intellectual disability (ID) requires certain nuances in approach that may be unfamiliar to some psychiatrists. In this article, we’ll discuss some aspects of assessment and treatment that you may find useful when you encounter and work with such patients.
You can't view details of this content, please login or buy subscription here